Investigating Ozempic
Bernadette Fisers
Add to My Podcasts
Episodes
About
Reviews
Promote
The Ozempic Blockbuster and the Mounjaro User
44 minutes
Posted Dec 7, 2024 at 6:20 pm.
0:00
44:10
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
In 2017 two respected Danish Scientists claimed that higher dosages of the GLP1 Semaglutide, which had been planned as a treatment for Obesity, were not supported by the Clinical trials. I look into this controversial statement.
Previous
Ozempic vs Saxenda - Who's The biggest loser?
Next
WTF Wegovy!!!
← See all 6 episodes of Investigating Ozempic